PASELLO, MICHELA
 Distribuzione geografica
Continente #
NA - Nord America 235
EU - Europa 114
AS - Asia 9
AF - Africa 1
OC - Oceania 1
SA - Sud America 1
Totale 361
Nazione #
US - Stati Uniti d'America 231
IT - Italia 36
DE - Germania 21
FR - Francia 16
BG - Bulgaria 10
IE - Irlanda 8
NL - Olanda 5
CA - Canada 4
GB - Regno Unito 4
FI - Finlandia 3
RU - Federazione Russa 3
SE - Svezia 3
VN - Vietnam 3
AE - Emirati Arabi Uniti 2
CN - Cina 2
CZ - Repubblica Ceca 2
UA - Ucraina 2
AU - Australia 1
CH - Svizzera 1
CL - Cile 1
HK - Hong Kong 1
JP - Giappone 1
ZA - Sudafrica 1
Totale 361
Città #
Columbus 32
Fairfield 24
Seattle 14
Ashburn 13
Bologna 12
Woodbridge 11
Bremen 10
Houston 10
Santa Cruz 10
Sofia 10
Buffalo 9
Dublin 8
Tappahannock 7
Chicago 6
Ann Arbor 5
Boardman 5
Rimini 5
Wilmington 5
Council Bluffs 4
Los Angeles 4
Amsterdam 3
Cambridge 3
Castenaso 3
Dong Ket 3
Helsinki 3
Ottawa 3
Paris 3
Southend 3
Stockholm 3
Crocetta 2
Fleming Island 2
Leawood 2
Leverkusen 2
Mountain View 2
Somma Lombardo 2
Sunnyvale 2
Washington 2
Wuhan 2
Bern 1
Boydton 1
Büdelsdorf 1
Clearwater 1
Denver 1
Edison 1
Faenza 1
Frankfurt am Main 1
Jersey City 1
Lake Forest 1
Las Vegas 1
Miami 1
Muizenberg 1
Norwalk 1
Pollenza 1
Provo 1
Ravenna 1
Reggio Emilia 1
Reston 1
Scandiano 1
Toronto 1
University Park 1
Totale 271
Nome #
Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations, file e1dcb333-0de2-7715-e053-1705fe0a6cc9 158
ROCK2 deprivation leads to the inhibition of tumor growth and metastatic potential in osteosarcoma cells through the modulation of YAP activity, file e1dcb333-819d-7715-e053-1705fe0a6cc9 82
ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis, file 91c53b78-ad18-44bc-a4bc-466049faa701 25
Bone Turnover Marker (BTM) Changes after Denosumab in Giant Cell Tumors of Bone (GCTB): A Phase II Trial Correlative Study, file 8e85b153-810a-4cc4-85b6-7f84f37fd826 22
Integrated molecular characterization of patient-derived models reveals therapeutic strategies for treating CIC-DUX4 sarcoma, file e1dcb339-265a-7715-e053-1705fe0a6cc9 20
Integrated molecular characterization of patient-derived models reveals therapeutic strategies for treating CIC-DUX4 sarcoma, file 9829c23c-a565-4fa3-87b2-566b1fa18734 14
Correction to: ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis, file a8b8f6f4-cfae-4a71-988d-cd99c6e7daf2 13
Polymorphic variants of IGF2BP3 and SENCR have an impact on predisposition and/or progression of Ewing sarcoma, file daa89f28-8c91-462e-b699-317507d8b4d6 12
Polymorphic variants of IGF2BP3 and SENCR have an impact on predisposition and/or progression of Ewing sarcoma, file 26c4f9a2-6e32-446c-87b1-ade387e080fe 9
Integrated molecular characterization of patient-derived models reveals therapeutic strategies for treating CIC-DUX4 sarcoma, file ec521a88-6ad8-4a3f-b445-93d3ccff6f9a 9
ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis, file 85d75039-af23-4841-92ba-535ea2d29803 3
Targeting CD99 compromises the oncogenic effects of the chimera EWS-FLI1 by inducing re-expression of zyxin and inhibition of Gli1 activity, file e1dcb338-e476-7715-e053-1705fe0a6cc9 2
Totale 369
Categoria #
all - tutte 1.516
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.516


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202051 0 0 0 0 3 5 7 7 11 9 5 4
2020/202158 6 5 2 4 7 5 5 3 4 5 8 4
2021/202250 6 6 5 1 5 2 2 3 0 3 13 4
2022/202380 1 1 14 15 6 2 5 0 10 10 15 1
2023/2024130 1 5 9 13 6 23 9 10 10 3 41 0
Totale 369